Usui Yoshihiko, Okunuki Youko, Hattori Takaaki, Takeuchi Masaru, Kezuka Takeshi, Goto Hiroshi, Usui Masahiko
Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan.
Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4607-13. doi: 10.1167/iovs.06-0181.
To examine the expression of various costimulatory molecules on the human retinoblastoma cell line Y-79 and assess the functional roles of selected costimulatory molecules.
Y-79 cells were incubated in the presence or absence of IFN-gamma, with or without irradiation (100 Gy). Expression of major histocompatibility complex (MHC) class I molecules, MHC class II, CD80, CD86, CD40, CD70, B7H1, B7DC, B7H2, OX40L, and 4-1BBL on Y-79 cells was measured by reverse transcription-polymerase chain reaction (RT-PCR) and flow cytometric analysis. The functional role of CD40-mediated interactions in modifying immune responses to Y-79 was assessed in vitro by using recombinant human CD40 ligand (rhCD40L). The costimulatory effect of B7H1-expressing IFN-gamma-treated Y-79 cells on proliferation of purified T cells was studied in Y-79/T-cell coculture experiments with a blocking anti-B7H1 monoclonal antibody (mAb).
CD40 and B7H2 were consistently detected on Y-79 cells by RT-PCR and flow cytometry. Cell surface expression of CD40 was upregulated on stimulation by IFN-gamma alone, radiation alone, and IFN-gamma combined with radiation. B7H1 expression was induced by IFN-gamma stimulation and increased further when irradiated Y-79 cells were stimulated by IFN-gamma. Treatment of Y-79 cells with rhCD40L enhanced cell surface expression of MHC class I and intercellular adhesion molecule (ICAM)-1 and also stimulated monocyte chemotactic protein (MCP)-1 production. Proliferative response of purified CD3+ T cells costimulated with IFN-gamma-stimulated Y-79 was significantly enhanced by the addition of anti-B7H1 mAb.
These results suggest that CD40 expressed on Y-79 plays an important role in augmenting antitumor immunity. In contrast, the expression of B7H1 on IFN-gamma-treated Y-79 cells contributes to the suppression of T cells. The dual effects of CD40 and B7H1 on Y-79 cells may contribute to positive or negative regulation of antitumor immune responses in human retinoblastoma.
检测人视网膜母细胞瘤细胞系Y-79上多种共刺激分子的表达,并评估所选共刺激分子的功能作用。
将Y-79细胞在有或无γ干扰素(IFN-γ)存在的情况下培养,有或无照射(100戈瑞)。通过逆转录-聚合酶链反应(RT-PCR)和流式细胞术分析检测Y-79细胞上主要组织相容性复合体(MHC)I类分子、MHC II类分子、CD80、CD86、CD40、CD70、B7H1、B7DC、B7H2、OX40L和4-1BBL的表达。通过使用重组人CD40配体(rhCD40L)在体外评估CD40介导的相互作用在改变对Y-79的免疫反应中的功能作用。在Y-79/T细胞共培养实验中,使用阻断性抗B7H1单克隆抗体(mAb)研究表达B7H1的经IFN-γ处理的Y-79细胞对纯化T细胞增殖的共刺激作用。
通过RT-PCR和流式细胞术在Y-79细胞上持续检测到CD40和B7H2。单独用IFN-γ刺激、单独照射以及IFN-γ与照射联合刺激时,CD40的细胞表面表达上调。B7H1的表达由IFN-γ刺激诱导,当照射后的Y-79细胞再用IFN-γ刺激时进一步增加。用rhCD40L处理Y-79细胞可增强MHC I类分子和细胞间黏附分子(ICAM)-1的细胞表面表达,还可刺激单核细胞趋化蛋白(MCP)-1的产生。添加抗B7H1 mAb可显著增强经IFN-γ刺激的Y-79共刺激的纯化CD3+ T细胞增殖反应。
这些结果表明Y-79上表达的CD40在增强抗肿瘤免疫中起重要作用。相反,经IFN-γ处理的Y-79细胞上B7H1的表达有助于抑制T细胞。CD40和B7H1对Y-79细胞的双重作用可能有助于对人视网膜母细胞瘤抗肿瘤免疫反应的正向或负向调节。